GL1X · GenesisL1 explorer

Research workbench

Unliganded form of O-succinylbenzoate coenzyme a synthetase (mene) from bacillus subtilis, solved at 1.98 ångströms

Analyse Unliganded form of O-succinylbenzoate coenzyme a synthetase (mene) from… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5BUQ
Type
protein
Length
927 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
2-succinylbenzoate--CoA ligase
EC
6.2.1.26
UniProt
P23971
Ligands
CA
Pockets
11 · best druggability 0.63

Structure

x-ray diffraction · 2 distinct chains · 33% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A2-succinylbenzoate--CoA ligase (EC 6.2.1.26)protein45433% helix, 28% strandP23971
B2-succinylbenzoate--CoA ligase (EC 6.2.1.26)protein47333% helix, 28% strandP23971

Ligands and binding sites

  • CA · Calcium ion · metal · chains B
  • ACT · Acetate ion · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14560.630.7750empty
24910.630.7673empty
32480.630.8136ACT
41940.620.8336empty
52180.560.7939empty

Interfaces

1 interface between chains.

  • A–B · 1237 Ų buried · 18 hydrogen bonds · protein-protein

Compared structures

  • 5BUQ · Unliganded Form of O-succinylbenzoate Coenzyme A Synthetase (MenE) from Bacillus… · the same entry in another collection · chain A against A, TM-score 1.00
  • P23971 · AlphaFold monomer V2.0 prediction for 2-succinylbenzoate--CoA ligase (P23971) · a predicted model of the same protein · chain A against A, TM-score 0.86

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.